{"id":91722,"date":"2016-12-12T19:57:02","date_gmt":"2016-12-12T19:57:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=91722"},"modified":"2016-12-12T19:57:02","modified_gmt":"2016-12-12T19:57:02","slug":"liquid-biopsy-market-size-analysis-trends-report-share-investment-opportunities-and-forecast-to-2022","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/liquid-biopsy-market-size-analysis-trends-report-share-investment-opportunities-and-forecast-to-2022_91722.html","title":{"rendered":"Liquid Biopsy Market size, Analysis, Trends, Report, Share, Investment Opportunities and Forecast to 2022"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2016\/12\/1456990356.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2016\/12\/1456990356.png\" alt=\"\" width=\"225\" height=\"73\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;Stratistics MRC, one stop shop for all your market research needs.&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">According to Stratistics MRC, the Global Liquid Biopsy market is expected to grow from $0.63 billion in 2015 to reach $2.93 billion by 2022 with a CAGR of 24.6%. Increasing research &#038; developments and clinical trials for diagnostics, and technological developments are some of the factors driving the market growth. Moreover, growing prevalence of cancer, increasing awareness about liquid biopsy are the factors fostering the market growth. <\/div>\n<p style=\"text-align: justify;\"><span>On the other hand, higher costs and complex regulations are restraining the market growth.&nbsp;<\/span>The circulating tumor cells leads the market globally with the biggest market share and is expected to grow with a high CAGR during the forecast period. By cancer type, lung cancer segment is expected to witness high growth rate during the forecast period. North America emerged as the major revenue generating region in the global market due to innovative technological developments, and increasing incidence of cancer rates in the Canada and U.S. Asia Pacific and Latin America are expected to witness high growth rate during the forecast period.<\/p>\n<p style=\"text-align: justify;\"><strong>Order a copy at<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"http:\/\/www.strategymrc.com\/report\/liquid-biopsy-market\" target=\"_blank\">http:\/\/www.strategymrc.com\/report\/liquid-biopsy-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><span>Some of the key players in global liquid biopsy market include Adaptive Biotechnologies, Biocept, Inc., Bio-Rad Laboratories Inc., Guardant Health Inc., Fraunhofer-Gesellschaft, F. Hoffmann-La Roche AG, Epic Sciences, Cynvenio, Illumina Inc., Qiagen, Personal Genome Diagnostics, NeoGenomics Laboratories, Myriad Genetics, Trovagene Inc., RainDance Technologies, MDX Health SA, and Janssen Diagnostics, LLC.&nbsp;<\/span><\/p>\n<p style=\"text-align: justify;\"><strong>Request for a sample at<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"http:\/\/www.strategymrc.com\/report\/liquid-biopsy-market\" target=\"_blank\">http:\/\/www.strategymrc.com\/report\/liquid-biopsy-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Scope of the Report:<\/strong><\/p>\n<p style=\"text-align: justify;\"><span><strong>Sample Types Covered:<\/strong><br \/>&bull; Urine<br \/>&bull; Blood<br \/>&bull; Others<br \/>o CSF<br \/>o Plasma<br \/>o Saliva<\/p>\n<p><strong>Cancer Types Covered:<\/strong><br \/>&bull; Gastrointestinal Cancer<br \/>&bull; Colorectal Cancer<br \/>&bull; Breast Cancer<br \/>&bull; Leukemia<br \/>&bull; Prostate Cancer<br \/>&bull; Lung Cancer<br \/>&bull; Liver Cancer<br \/>&bull; Other Cancers<br \/>o Ovarian Cancer<br \/>o Melanoma<br \/>o Bladder Cancer<\/p>\n<p><strong>Circulating Biomarkers Covered:<\/strong><br \/>&bull; Extracellular Vesicles (EVs)<br \/>&bull; Circulating Tumor DNA (ctDNA)<br \/>&bull; Exosomes<br \/>&bull; Circulating Tumor Cells (CTCs)<br \/>&bull; Other Biomarkers<br \/>o Circulating RNA and Protein<\/p>\n<p><strong>Products and Services Covered:<\/strong><br \/>&bull; Services and Software<br \/>&bull; Reagents<br \/>&bull; Instruments<\/p>\n<p><strong>End Users Covered:<\/strong><br \/>&bull; Hospital and Physician Laboratories<br \/>&bull; Diagnostic Centers<br \/>&bull; Academic &amp; Research Centers<br \/>&bull; Others End User<br \/>o Small Molecular Laboratories<br \/>o Public Health Laboratories<br \/>o Pathology Laboratories<\/p>\n<p><strong>Regions Covered:<\/strong><br \/>&bull; North America<br \/>o US<br \/>o Canada<br \/>o Mexico<br \/>&bull; Europe<br \/>o Germany<br \/>o France<br \/>o Italy<br \/>o UK&nbsp;<br \/>o Spain&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br \/>o Rest of Europe&nbsp;<br \/>&bull; Asia Pacific<br \/>o Japan<br \/>o China<br \/>o India<br \/>o Australia<br \/>o New Zealand<br \/>o Rest of Asia Pacific<br \/>&bull; Rest of the World<br \/>o Middle East<br \/>o Brazil<br \/>o Argentina<br \/>o South Africa<br \/>o Egypt<\/p>\n<p><strong>What our report offers:<\/strong><br \/>&#8211; Market share assessments for the regional and country level segments<br \/>&#8211; Market share analysis of the top industry players<br \/>&#8211; Strategic recommendations for the new entrants<br \/>&#8211; Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets<br \/>&#8211; Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)<br \/>&#8211; Strategic recommendations in key business segments based on the market estimations<br \/>&#8211; Competitive landscaping mapping the key common trends<br \/>&#8211; Company profiling with detailed strategies, financials, and recent developments<br \/>&#8211; Supply chain trends mapping the latest technological advancements<\/span><\/p>\n<p style=\"text-align: justify;\"><strong>Follow us on LinkedIn:&nbsp;<\/strong><strong><br \/><\/strong><a rel=\"nofollow\" href=\"https:\/\/www.linkedin.com\/company\/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile\" >https:\/\/www.linkedin.com\/company\/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Follow us on Twitter:<\/strong><strong><br \/><\/strong><a rel=\"nofollow\" href=\"https:\/\/twitter.com\/StratisticsMRC\"  target=\"_blank\">https:\/\/twitter.com\/StratisticsMRC<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>About Stratistics MRC<\/strong><\/p>\n<p style=\"text-align: justify;\">We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends.<\/p>\n<p style=\"text-align: justify;\">Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.<\/p>\n<p style=\"text-align: justify;\"><strong>For more information, please visit<\/strong>&nbsp;<a rel=\"nofollow\" href=\"http:\/\/www.strategymrc.com\/\"  target=\"_blank\">Stratistics Market Research Consulting&nbsp;Pvt Ltd<\/a><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> Stratistics Market Research Consulting<br \/><strong>Contact Person:<\/strong> James Lamb<br \/><strong>Email:<\/strong> info@strategymrc.com<br \/><strong>Phone:<\/strong> +1-301-202-5929<br \/><strong>City:<\/strong> Gaithersburg<br \/><strong>State:<\/strong> Maryland<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.strategymrc.com\" target=\"_blank\" rel=\"nofollow\">www.strategymrc.com<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.strategymrc.com\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=liquid-biopsy-market-size-analysis-trends-report-share-investment-opportunities-and-forecast-to-2022\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Stratistics MRC, one stop shop for all your market research needs.&#8221; According to Stratistics MRC, the Global Liquid Biopsy market is expected to grow from $0.63 billion in 2015 to reach $2.93 billion by 2022 with a CAGR of 24.6%. &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/liquid-biopsy-market-size-analysis-trends-report-share-investment-opportunities-and-forecast-to-2022_91722.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-91722","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/91722","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=91722"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/91722\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=91722"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=91722"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=91722"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}